Literature DB >> 16005365

High prevalence of metabolic syndrome in Hong Kong Chinese--comparison of three diagnostic criteria.

Gary Tin-Choi Ko1, Clive Stewart Cockram, Chun-Chung Chow, Vincent Yeung, Wing-Bun Chan, Wing-Yee So, Norman Nor Chan, Juliana Chun-Ngor Chan.   

Abstract

The World Health Organisation (WHO), European Group for the Study of Insulin Resistance (EGIR) and National Cholesterol Education Program (NCEP) Expert Panels had introduced definitions for the metabolic syndrome (MES). We aimed to estimate the prevalence of MES in a working population in Hong Kong using the three definitions for MES and compare their relative significance. The data are obtained from a prevalence survey for glucose intolerance and lipid abnormality in a Hong Kong Chinese working population. The distribution of occupational groups in these subjects was similar to that recorded in the Hong Kong Census (1991) and representative of the Hong Kong working population. Definition of obesity was modified using the Asian criterion of body mass index (BMI)> or =25 kg/m 2, waist circumference>80 cm in women and >90 cm in men. Of the 1513 subjects, 910 (60.1%) were men and 603 (39.9%) were women. The mean age was 37.5+/-9.2 (median 37.0 years, range 18-66 years). Using the Asian definition for obesity, the prevalence of MES using the WHO criterion was the highest (WHO versus EGIR versus NCEP-overall: 13.4% versus 8.9% versus 9.6%, p<0.001; under age of 40 years: 7.9% versus 4.9% versus 5.4%, p=0.017; age of 40 years or above: 21.9% versus 14.9% versus 16.0%, p=0.003). The prevalence of different components of the MES ranged from 6 to 38%. In subjects aged less than 50 years, there was a male preponderance for MES (male versus female-WHO: 9.5% versus 6.2%, p=0.007; EGIR: 7.9% versus 6.2%, p=0.235; NCEP: 9.5% versus 6.2%, p=0.030) but this trend was reversed after the age of 50 years (WHO: 29.3% versus 31.9%, p=0.721; EGIR: 13.1% versus 34.8%, p=0.001; NCEP: 19.2% versus 23.2%, p=0.533). The prevalence of MES in Hong Kong Chinese of working age ranges from 6.1 to 13.4% depending on various diagnostic criteria. There was a male preponderance before the age of 50 years and a female-preponderance after the age of 50 years. The inclusion of albuminuria and insulin resistance by the WHO has made it the most discriminative criterion in identifying at risk individuals in all age groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005365     DOI: 10.1016/j.diabres.2004.11.015

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  24 in total

1.  Prevalence of metabolic syndrome in rural and urban Chinese population in Qingdao.

Authors:  J Zhao; Z C Pang; L Zhang; W G Gao; S J Wang; F Ning; H R Nan; J Ren; Q Qiao
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Association of serum NO( x ) level with clustering of metabolic syndrome components in middle-aged and elderly general populations in Japan.

Authors:  Jun Ueyama; Takaaki Kondo; Ryota Imai; Akiko Kimata; Kanami Yamamoto; Koji Suzuki; Takashi Inoue; Yoshinori Ito; Ken-Ichi Miyamoto; Takaaki Hasegawa; Nobuyuki Hamajima
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

3.  Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant.

Authors:  Leopold Fezeu; Beverley Balkau; André-Pascal Kengne; Eugène Sobngwi; Jean-Claude Mbanya
Journal:  Atherosclerosis       Date:  2006-10-02       Impact factor: 5.162

4.  Survival benefit of abdominal adiposity: a 6-year follow-up study with Dual X-ray absorptiometry in 3,978 older adults.

Authors:  Jenny Shun Wah Lee; Tung Wai Auyeung; Timothy Kwok; Martin Li; Jason Leung; Jean Woo
Journal:  Age (Dordr)       Date:  2011-06-11

5.  Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies.

Authors:  Sheng Hui Wu; Wu Sheng Hui; Zhong Liu; Suzanne C Ho
Journal:  Eur J Epidemiol       Date:  2010-04-28       Impact factor: 8.082

6.  Metabolic syndrome and type 2 diabetes: the Hong Kong perspective.

Authors:  Norman N Chan; Alice P S Kong; Juliana C N Chan
Journal:  Clin Biochem Rev       Date:  2005-08

7.  Non-alcohol fatty liver disease in Asia: Prevention and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-07-08

8.  Depressive symptoms and change in abdominal obesity in the elderly: positive or negative association?

Authors:  Samuel Y S Wong; Jason C Leung; Ping C Leung; Jean Woo
Journal:  Am J Geriatr Psychiatry       Date:  2011-08       Impact factor: 4.105

9.  Overweight, family history of diabetes and attending schools of lower academic grading are independent predictors for metabolic syndrome in Hong Kong Chinese adolescents.

Authors:  Risa Ozaki; Qing Qiao; Gary W K Wong; Michael H M Chan; Wing-Yee So; Peter C Y Tong; C S Ho; Gary Tin-Choi Ko; Alice P S Kong; Christopher W K Lam; Jaakko Tuomilehto; Juliana C N Chan
Journal:  Arch Dis Child       Date:  2006-11-06       Impact factor: 3.791

10.  Low levels of awareness of suboptimal health conditions in a high-risk working population: the "better health for better Hong Kong" health promotion campaign.

Authors:  Gary T C Ko; Juliana C N Chan; Amy W Y Chan; Patrick T S Wong; Stanley S C Hui; Spencer D Y Tong; Ferrie Chow; Cecilia L W Chan
Journal:  Int J Behav Med       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.